AKBA
USDAkebia Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.630
High
$3.630
Low
$3.560
Volume
4.93M
Company Fundamentals
Market Cap
950.7M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
5.05M
Exchange
NCM
Currency
USD
52-Week Range
Related News
HC Wainwright & Co. Assumes Akebia Therapeutics at Buy, Announces Price Target of $8
HC Wainwright & Co. analyst Matthew Caufield assumes Akebia Therapeutics with a Buy rating and announces Price Target of $8.
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three
Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
Related Stocks
LPCN
Lipocine Inc.
AGNCM
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AFB
AllianceBernstein National Municipal Income Fund Inc
ABVC
ABVC BioPharma Inc.
BMRC
Bank of Marin Bancorp
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.